F U Cancer Quotes

procedures each year. Table 2.5 shows inequities, though possibly not as consistently as for the cancer measure; 22.7 percent of whites received all four procedures within a year, compared to 18.7 percent of Hispanics and 16.6 percent of blacks. Income differences ranged from a high 27.8 percent of the 400 percent or more of the poverty level to a low 16.2 percent

What’s good for you isn’t necessarily good for others—and vice versa. Consider this story: In 1985, a discovery by a major U.S. pharma firm led to a significant success in breast cancer treatment in two animal species. The phase I human trials showed no major safety concerns, but the study failed in phase II. The problem was with the cohort that was used. Half the patients had a gene that failed to metabolize the drug and they developed toxicity; the other half had a gene that metabolized the drug so quickly that it had no effect. When this problem was finally discovered in 2010 after gene sequencing of humans and of their tumors became more common, researchers realized that this beneficial drug had not helped the hundreds of thousands it could have since 1985. The point: The Human Genome Project has led to a better understanding of why something can be bad for some but good for others. That has led to scientific progress that is letting us live younger for longer.